scispace - formally typeset
C

Chris Theriault

Researcher at Dalhousie University

Publications -  30
Citations -  1257

Chris Theriault is an academic researcher from Dalhousie University. The author has contributed to research in topics: Lupus erythematosus & Population. The author has an hindex of 16, co-authored 26 publications receiving 957 citations. Previous affiliations of Chris Theriault include Halifax & Queen Elizabeth II Health Sciences Centre.

Papers
More filters
Journal ArticleDOI

The frequency and outcome of lupus nephritis: results from an international inception cohort study

John G. Hanly, +44 more
- 01 Feb 2016 - 
TL;DR: Despite current standard of care, nephritis was associated with ESRD and death, and renal insufficiency was linked to lower health-related quality of life.
Journal ArticleDOI

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

TL;DR: Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage, and there was an association with disease activity but not with autoantibodies.
Journal ArticleDOI

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

TL;DR: LA and anti-ribosomal P antibodies are associated with an increased future risk of intracranial thrombosis and lupus psychosis, respectively.
Journal ArticleDOI

Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

John G. Hanly, +41 more
TL;DR: To examine the frequency, characteristics, and outcome of mood disorders, as well as clinical and autoantibody associations, in a multiethnic/racial, prospective inception cohort of patients with systemic lupus erythematosus (SLE).
Journal ArticleDOI

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

John G. Hanly, +41 more
TL;DR: Headache is frequent in SLE, but overall, it is not associated with global disease activity or specific autoantibodies, and although headaches are associated with a lower HRQOL, the majority of headaches resolve over time, independent of lupus-specific therapies.